Vanderbilt Institute for Global Health

Home » News Posts » ID Grand Rounds: August/September

ID Grand Rounds: August/September

Posted by on Monday, August 4, 2014 in News Posts.

Thursday – 12:00pm to 1:00 pm
Presented in A-2200 of Medical Center North (MCN) with
Video Teleconferencing (VTC) to the 5th Floor Conference Room at 100 Oaks.

August 14
W. David Hardy, MD
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
“HIV and Reproductive Health”

September 4
Sten Vermund, MD
Amos Christie Chair and Professor of Pediatrics
Director, Vanderbilt Institute for Global Health
“Circumcision for HIV prevention: where are we and where do we need to go?”

September 11
Lindsay Grayson, MD
Professor at Austin Health Hopital and Health Center
University of Melbourne
“Antibiotic Resistance”

September 18
Madan Jagasia, MD
Section Chief, Hematology & Stem Cell Transplant
Director, Outpatient Transplant Unit
Vanderbilt University
“Clostridia difficile in Stem Cell Patients”

September 25
David Kim, MD
Instructor, Cardiovascular Medicine Division
Vanderbilt University
“Clinical Features, Management and Outcomes of Cardiac Implantable Electronic Device (CIED) Endocarditis”

Sponsored by
Vanderbilt University School of Medicine
Division of Infectious Diseases

Vanderbilt University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vanderbilt University School of Medicine designates this live activity for a maximum of one (1) AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

It is the policy of the ACCME and Vanderbilt University School of Medicine to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity.  Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.

Contact for more information.

Tags: , ,